The global point of care (PoC) lipid test market is projected to grow at a CAGR of 5.0% from 2025 to 2033, driven by the rising burden of cardiovascular and metabolic disorders, increasing preference for early disease detection, and growing demand for decentralized diagnostics. PoC lipid testing devices enable rapid, on-site measurement of cholesterol, triglycerides, HDL, and LDL levels, facilitating timely diagnosis and intervention in clinical and non-clinical settings. As healthcare systems continue to shift toward preventive care and patient-centric models, PoC lipid testing is becoming integral to routine screenings, particularly in primary care clinics, pharmacies, mobile units, and community health programs.
The home sleep screening devices market is projected to grow at a CAGR of 7.2% during the forecast period 2025 to 2033, driven by increasing awareness of sleep disorders, technological innovations in compact monitoring systems, and the rising preference for non-invasive and accessible home-based diagnostics. Home sleep screening devices, including wearable and non-wearable types, offer an affordable and patient-centric alternative to in-lab polysomnography, enabling continuous data tracking for accurate sleep analysis.
The bovine tuberculosis diagnosis market is expected to grow at a CAGR of 7.7% during the forecast period of 2025 to 2033. Bovine tuberculosis (bTB) is a chronic disease among cattle caused by the bacterium Mycobacterium bovis, closely related to the bacteria that causes tuberculosis in humans. This disease has a significant impact on livestock worldwide due to its ability to spread rapidly among herds and its potential for transmission to humans, primarily through unpasteurized milk and direct contact.
The gas exchange pulmonary function testing market is expected to grow at a CAGR of 6.0% during the forecast period of 2025 to 2033. Gas exchange pulmonary function testing market comprises diagnostic tools used to assess the respiratory function by measuring gas transfer in the lungs. This market has gained prominence due to the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis. These tests help in diagnosing the extent of lung damage, monitoring disease progression, and guiding treatment decisions.
The femtech market is expected to grow at a CAGR of 12.7% during the forecast period of 2025 to 2033. Femtech, or female technology, encompasses a range of products, software, and diagnostics that focus on women's health, including reproductive health, pregnancy and nursing care, pelvic and uterine healthcare, menstrual health, and sexual wellness. The market is gaining traction as it addresses long-underrepresented areas in healthcare through the integration of technology, medical insights, and consumer-centric approaches.
The automotive fault diagnostic scan tools market is expected to grow at a CAGR of 6.5% during the forecast period of 2025 to 2033. Automotive fault diagnostic scan tools market encompasses devices and software used for identifying issues within vehicle electronic systems. These tools are essential in the automotive industry, aiding technicians in diagnosing and repairing faults efficiently. The market is influenced by the increasing complexity of automotive electronics, the growth in automotive production and ownership, and regulatory pressures for lower emissions and safer vehicles.
The rabies diagnostics market is expected to grow at a CAGR of 5.1% during the forecast period of 2025 to 2033, due to several critical factors driving demand for effective diagnostic solutions. Key conclusions indicate that the market is heavily influenced by the rising incidence of rabies, advancements in diagnostic technologies, and increased funding for rabies control initiatives.
The genetic testing market is expected to grow at a CAGR of 22.7% during the forecast period of 2025 to 2033, driven by advancements in technology, increasing awareness of genetic disorders, and the rising demand for personalized medicine. Genetic testing involves analyzing DNA to identify changes or mutations that may lead to genetic disorders or predispositions to certain health conditions. In 2025, the market generated substantial revenue, largely due to the widespread adoption of next-generation sequencing (NGS) and the growing prevalence of genetic diseases.
The neurovascular catheters market is expected to grow at a CAGR of 7.25% during the forecast period of 2025 to 2033. The nuanced analysis reveals the significance of technological advancements, the increasing prevalence of neurological disorders, and evolving applications in driving market dynamics. As the market evolves, a strategic approach to address regulatory challenges and capitalize on emerging opportunities will be crucial for sustained growth and competitiveness.
The magnetic beads market is expected to grow at a CAGR of 5% during the forecast period of 2025 to 2033, driven by advancements in biotechnology, diagnostics, and healthcare. The magnetic beads market is at the forefront of transformative advancements in biotechnology and diagnostics, offering versatile solutions across various industries. The magnetic beads market is witnessing a surge in demand, underpinned by their pivotal role in nucleic acid isolation, healthcare monitoring, and space exploration applications.
The global market for diagnostic testing is expected to surpass US $350 billion by 2030, expanding at a CAGR of 9% from 2023 to 2030.
Diagnostic tests are medical examinations performed to aid in the recognition or diagnosis of any disease. These tests are crucial for the management, surveillance, and prevention of any disease. These tests increase patient care, customer security, and healthcare expenditures. According to the study Non-communicable Illnesses Important Statistics from the World Health Organization (WHO), chronic diseases will be responsible for approximately 41 million deaths annually by April 2021, or 71 percent of all deaths worldwide. Hence, diagnostic tests have proved beneficial in the prevention, identification, and diagnosis of disease, as well as in the management of chronic sickness situations. By detecting individual risk factors and early warning signs, clinical diagnostics create new opportunities for early prevention and intervention. Thus, it is projected that the industry as a whole would continue to expand as the prevalence of chronic diseases rises.
The industry is expected to be driven by the increasing popularity of decentralized healthcare systems. In addition, it is predicted that the market would expand during the forecast period as a result of leading market players' adoption of new innovations and technical advancements in the sector. As a result of these reasons, the market for point-of-care diagnostics is predicted to expand in the future years. The aging of the world's population increases the likelihood of contracting a variety of diseases, including diabetes, cancer, cardiovascular disease, obesity, and neurological disorders. The United Nations projects that by 2020, 727 million people worldwide would be 65 or older. In addition, it is estimated that by 2050, there will be more than 1.5 billion individuals aged 80 and older, which is twice as many as there are today. The predicted growth in the global elderly population during the forecast period is likely to have a substantial impact on the market.
Acute Market Reports, a market research and consulting company remains the best choice for industry participants in the diagnostics domain. Acute Market Reports' clients gain from our forward-thinking research technique, which aids in the development of well-informed business decisions. With the help of our extensive network of business partners, we are able to offer innovative strategic research solutions to our global clients.
